Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,221 to 1,240 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysis. | Antiviral Res | 2022 | 35033572 | PubTator, text mining | PubMed |
| A multi-targeted approach to identify potential flavonoids against three targets in the SARS-CoV-2 life cycle. | Comput Biol Med | 2022 | 35032740 | PubTator, text mining | PubMed |
| Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses. | Cell Chem Biol | 2022 | 35021060 | PubTator, text mining | PubMed |
| Identification of key tumor stroma-associated transcriptional signatures correlated with survival prognosis and tumor progression in breast cancer. | Breast Cancer | 2022 | 35020130 | PubTator, text mining | PubMed |
| EZH2 depletion potentiates MYC degradation inhibiting neuroblastoma and small cell carcinoma tumor formation. | Nat Commun | 2022 | 35013218 | PubTator, text mining | PubMed |
| Knockout of circRNAs by base editing back-splice sites of circularized exons. | Genome Biol | 2022 | 35012611 | PubTator, text mining | PubMed |
| Coronaviruses Nsp5 Antagonizes Porcine Gasdermin D-Mediated Pyroptosis by Cleaving Pore-Forming p30 Fragment. | mBio | 2022 | 35012343 | PubTator, text mining | PubMed |
| Merbromin is a mixed-type inhibitor of 3-chyomotrypsin like protease of SARS-CoV-2. | Biochem Biophys Res Commun | 2022 | 35007835 | PubTator, text mining | PubMed |
| Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CLpro covalent inhibitors. | Eur J Med Chem | 2022 | 34995923 | PubTator, text mining | PubMed |
| COVID-19 pandemic: impacts on bees, beekeeping, and potential role of bee products as antiviral agents and immune enhancers. | Environ Sci Pollut Res Int | 2022 | 34993785 | PubTator, text mining | PubMed |
| Interferon Control of Human Coronavirus Infection and Viral Evasion: Mechanistic Insights and Implications for Antiviral Drug and Vaccine Development. | J Mol Biol | 2022 | 34990653 | PubTator, text mining | PubMed |
| Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance. | J Chem Inf Model | 2022 | 34989238 | PubTator, text mining | PubMed |
| Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery. | Comput Biol Med | 2022 | 34986429 | PubTator, text mining | PubMed |
| Exostosin glycosyltransferase 1 reduces porcine reproductive and respiratory syndrome virus infection through proteasomal degradation of nsp3 and nsp5. | J Biol Chem | 2022 | 34971707 | PubTator, text mining | PubMed |
| A virus-specific monocyte inflammatory phenotype is induced by SARS-CoV-2 at the immune-epithelial interface. | Proc Natl Acad Sci U S A | 2022 | 34969849 | PubTator, text mining | PubMed |
| Comparative mutational analysis of SARS-CoV-2 isolates from Pakistan and structural-functional implications using computational modelling and simulation approaches. | Comput Biol Med | 2022 | 34968862 | PubTator, text mining | PubMed |
| Investigation of small molecule inhibitors of the SARS-CoV-2 papain-like protease by all-atom microsecond modelling, PELE Monte Carlo simulations, and in vitro activity inhibition. | Chem Phys Lett | 2022 | 34961797 | PubTator, text mining | PubMed |
| Identification of potent food constituents as SARS-CoV-2 papain-like protease modulators through advanced pharmacoinformatics approaches. | J Mol Graph Model | 2022 | 34959151 | PubTator, text mining | PubMed |
| Circ_0000745 promotes acute lymphoblastic leukemia progression through mediating miR-494-3p/NET1 axis. | Hematology | 2022 | 34957935 | PubTator, text mining | PubMed |
| A Charge-Switchable Zwitterionic Peptide for Rapid Detection of SARS-CoV-2 Main Protease. | Angew Chem Int Ed Engl | 2022 | 34936725 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=62